SHILPA MEDICARE LTD (SHILPAMED)

NSE: ₹525.80
BSE: ₹526.10
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain.

2026-06-03 09:29:31
USFDA Inspection Of Shilpa Medicare Ltd At Unit VI, Dabaspet, Bengaluru

USFDA Inspection of Shilpa Medicare Limited at Unit VI, Dabaspet, Bengaluru

2026-05-30 15:45:09
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the financial year 2025-26

2026-05-28 12:55:56
Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of the Q4FY26 Conference call

2026-05-26 13:49:49
Announcement under Regulation 30 (LODR)-Newspaper Publication

Postal Ballot notice published in news paper.

2026-05-23 14:56:15
Announcement under Regulation 30 (LODR)-Newspaper Publication

Postal Ballot notice published in newspaper

2026-05-23 14:49:46
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Analyst/Investor Call -Call Recording

2026-05-22 18:33:37
Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation for the period - Q4FY26

2026-05-22 15:21:16
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Notice of Postal Ballot

2026-05-22 15:11:17
Announcement under Regulation 30 (LODR)-Dividend Updates

Board Recommended final dividend of Re.0.60/- per equity shares of face value of Re.1/- each

2026-05-22 15:00:22

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 83.74 74.61 63.98 87.45 96.12 129.68 125.39 126.15 92.43 134.93 165.70 201.11
YOY Revenue Growth % 37.65% 8.56% 23.89% 31.52% 14.78% 73.8% 95.98% 44.26% -3.84% 4.05% 32.16% 59.42%
Other Income 20.78 22.76 22.33 23.25 31.45 21.47 16.83 14.08 17.79 16.94 11.29 6.89
Total Income 104.52 97.38 86.31 110.70 127.57 151.15 142.21 140.24 110.22 151.88 176.99 208.00
Total Expenses + 87.42 85.17 82.28 75.15 86.42 100.04 104.56 105.35 90.26 111.39 151.00 158.35
Cost of Materials Consumed 13.77 22.27 10.46 27.13 14.20 22.11 28.97 34.54 38.03 45.73 54.03 67.38
Employee Benefit Expense 27.80 26.23 25.34 24.28 26.36 27.02 23.54 22.69 27.68 28.47 30.75 30.01
Other Expenses 21.20 22.42 23.48 23.73 22.14 36.20 52.06 22.23 20.07 21.41 32.04 33.18
Operating Profit -3.68 -10.55 -18.30 12.31 9.70 29.65 20.83 20.81 2.18 23.55 14.70 42.76
OPM % -4.4% -14.1% -28.6% 14.1% 10.1% 22.9% 16.6% 16.5% 2.4% 17.5% 8.9% 21.3%
Profit Before Tax + 10.76 11.99 3.91 11.43 40.69 50.65 25.33 -9.43 14.79 38.92 23.79 78.02
Tax Expense 2.86 5.39 1.21 1.69 12.34 20.16 9.21 -4.28 -5.91 8.10 7.85 7.05
Tax % 26.6% 45% 31% 14.8% 30.3% 39.8% 36.4% - -40% 20.8% 33% 9%
Profit After Tax 7.90 6.60 2.70 9.74 28.35 30.49 16.12 -5.15 20.70 30.83 15.93 70.97
EPS (Basic) 0.91 0.76 0.31 1.12 2.94 3.12 1.65 -0.53 2.12 1.58 0.84 3.63

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 597.03 477.34 309.79 247.70 356.95 830.32 805.97
YOY Revenue Growth % 25.07% 54.09% 25.06% -30.61% -57.01% 3.02% -
Other Income 38.14 83.83 89.12 68.64 40.86 33.90 11.26
Total Income 635.17 561.18 398.90 316.35 397.81 864.22 817.23
Total Expenses + 506.46 408.20 268.11 359.08 379.14 661.63 571.40
Cost of Materials Consumed 205.99 99.83 73.87 59.12 75.19 303.57 275.90
Employee Benefit Expense 110.99 99.61 103.64 110.45 110.57 175.62 149.28
Other Expenses 105.86 132.63 90.60 99.05 145.91 171.09 146.22
Operating Profit 90.57 69.14 41.68 -111.37 -22.19 168.69 234.57
OPM % 15.2% 14.5% 13.5% -45% -6.2% 20.3% 29.1%
Profit Before Exceptional 128.71 152.98 48.54 -42.73 18.68 202.59 216.88
Exceptional Items 19.42 -45.74 -10.45 -15.55 8.81 52.95 -4.54
Profit Before Tax + 148.13 107.24 38.09 -58.28 27.49 255.54 212.34
Tax Expense 15.16 37.43 11.15 -115.47 -113.50 71.15 18.62
Tax % 10.2% 34.9% 29.3% - -413% 27.8% 8.8%
Profit After Tax 132.97 69.80 26.94 57.19 140.99 184.39 193.72
EPS (Basic) 6.80 7.16 3.10 6.59 16.87 22.62 23.76

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 2,502.29 2,529.38 2,041.66 1,882.41 1,691.87 1,737.15 0.00
Property, Plant & Equipment 462.87 440.61 483.46 495.63 527.39 602.59 0.00
Capital Work in Progress 36.80 39.46 9.92 41.84 52.57 297.19 0.00
Non-Current Investments 1,222.77 1,279.50 246.45 243.92 237.50 219.32 0.00
Goodwill 3.85 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 152.08 129.47 102.87 91.95 17.48 38.31 0.00
Current Assets + 526.26 477.29 376.93 634.95 309.79 780.24 0.00
Inventories 175.03 148.58 111.92 94.50 101.77 299.08 0.00
Trade Receivables 222.66 190.52 143.82 111.90 102.73 218.27 0.00
Cash and Cash Equivalents 9.15 3.29 2.92 4.58 15.55 115.01 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 2,713.38 2,700.59 0.00 2,117.58 2,065.67 1,637.83 0.00
Equity Share Capital 19.56 9.78 8.68 8.68 8.68 8.15 0.00
Other Equity 2,693.82 2,690.81 2,134.04 2,108.90 2,056.99 1,629.68 0.00
Non-Current Liabilities 38.75 79.18 49.53 158.37 210.15 412.11 0.00
Current Liabilities 276.42 226.89 226.34 241.41 161.65 467.45 0.00
Total Liabilities 315.17 306.07 275.87 399.77 830.45 879.56 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 60.00 -19.06 8.03 2.08 173.87 80.71 0.00
Cash from Investing Activities -67.15 -433.29 155.82 -94.80 -378.97 -249.21 0.00
Cash from Financing Activities 13.76 450.09 -163.07 87.68 97.23 -255.58 0.00
Net Increase/Decrease in Cash 6.11 -0.04 0.78 -5.04 -107.88 -424.08 0.00